| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,442 |
1,383 |
$83K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
297 |
286 |
$28K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
784 |
509 |
$18K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
201 |
197 |
$10K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
53 |
53 |
$4K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
421 |
421 |
$4K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
140 |
135 |
$3K |
| 96127 |
|
191 |
191 |
$2K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
169 |
167 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
108 |
107 |
$1K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
15 |
15 |
$1K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
12 |
12 |
$936.00 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
14 |
14 |
$433.30 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
28 |
27 |
$408.80 |
| 90461 |
|
12 |
12 |
$393.60 |
| 99441 |
|
12 |
12 |
$129.24 |
| 99000 |
|
12 |
12 |
$12.00 |